‘Elevated survival charges’ for bladder most cancers sufferers given immunotherapy drug

0
13
‘Elevated survival charges’ for bladder most cancers sufferers given immunotherapy drug


This can be a main breakthrough within the therapy of bladder most cancers. For a few years, survival charges for superior bladder most cancers have remained stagnant, however our findings provide hope to hundreds of sufferers who face this devastating analysis

Professor James Catto, College of Sheffield


Supply hyperlink